Labcorp, an American healthcare company, completed the acquisition of a clinical laboratory from Enzo Biochem, a biotechnology company. Financial terms were not disclosed. “The closing of this asset sale demonstrates our commitment to enhancing shareholder value. With the closing of this transaction, Enzo Biochem would like to express its profound gratitude to the generations of employees and physician partners who have dedicated themselves to providing the highest level of care and service to our patients. We are confident that Labcorp will continue to enrich and enhance the level of care and service that our physicians and patients have come to expect,” Hamid Erfanian, Enzo Biochem CEO.